Abstract
Purpose Endothelin-1, and constitutive endothelial nitric oxide synthase, have been implicated in the pathogenesis of diabetic retinopathy. We therefore screened polymorphisms within the genes encoding these two vasoactive agents in a sample of individuals with 15 years of diabetes and no retinopathy (ETDRS level 10 or better) and those with severe retinopathy (ETDRS level 50 or worse).
Methods PCR primers for highly polymorphic sites within the EDN1 and NOS3 genes were used to genotype individuals with type 1 or type 2 diabetes with severe or no retinopathy. Allele frequencies were compared between groups using chi-squared analysis and adjusting for multiple comparisons.
Results No significant differences were observed in allele frequencies for these two markers between the patients who had retinopathy and the patients who did not.
Conclusion Polymorphic variability in the EDN1 and NOS3 genes does not appear to have a major impact on determining susceptibility or resistance to diabetic retinopathy.
Similar content being viewed by others
Article PDF
References
Cogan DG, Toussaint D, Kuwabarra T . Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol 1961;66:366–78.
Poston L, Taylor PD . Endothelium-mediated vascular function in insulin dependent diabetes mellitus. Clin Sci 1995;88:245–55.
Stehouwer CDA, Lambert J, Donker AJM, van Hinsberg VWM . Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997;34:55–68.
Feener EP, King GL . Vascular dysfunction in diabetes mellitus. Lancet 1997;350:9–13.
Brenner BM, Troy JL, Ballerman BJ . Endothelium-dependent vascular responses: mediators and mechanisms. J Clin Invest 1989;84:1373–8.
McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, et al. Impaired endothelial-dependent and independent vasodilation in patients with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1992;35:771–6.
Tesfamariam B, Brown ML, Deykin D, Coehn RA . Elevated glucose promotes generation of endothelium-derived vasoconstrictor protanoids in rabbit aorta. J Clin Invest 1990;85:929–32.
Ye X, Laties AM, Stone RA . Peptidergic enervation of the retinal vasculature and optic nerve head. Invest Ophthalmol 1990;31:1731–7.
Moss SE, Klein R, Klein BEK . Ten-year incidence of visual loss in a diabetic population. Ophthalmology 1994;101:1061–70.
Clustering of long term complications in families with diabetes in the Diabetes Control & Complications Trial. Diabetes 1997;46:1829–39.
Leslie RDG, Pyke DA . Diabetic retinopathy in identical twins. Diabetes 1982;31:19–21.
Guillausseau PJ, Tielmans D, Virally-Monod M, Assayag M . Diabetes: from phenotypes to genotypes. Diabetes Metab 1997;23:14–21.
Chakravarthy U, Hayes RG, Stitt AW, McAuley E, Archer DB . Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. Diabetes 1998;47:945–52.
Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai N, et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 1994;368:703–10.
Rudic RD, Sheseley EG, Maeda N, Smithies O, Segal SS, Sessa WC . Direct evidence for the importance of endotheliumderived nitric oxide in vascular remodelling. J Clin Invest 1998;101:731–6.
Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC . Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239–42.
Diabetic Retinopathy Study Research Group. A modification of the Airlie House classification of diabetic retinopathy. Diabetic Retinopathy Study Research Group no. 7. Invest Ophthalmol 1981;21:210–6.
Pages J-C, Drieu C, Blanche H, Beckmann J, Cann HM . A short tandem repeat polymorphism at the endothelin-1 (EDN1) locus. Hum Mol Genet 1993;2:90.
Nadaud S, Bonnardeaux MD, Lathrop M, Soubrier F . Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 1994;198:1027–33.
Bonnardeaux A, Nadaud S, Charru A, Jeunmaitre X, Corvol P, Soubrier F . Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Circulation 1995;91:96–102.
Warpeha KM, Ah-Fat F, Harding S, Hart PM, Hughes AE, Chakravarthy U . Polymorphic variability in NOS2 gene may after susceptibility to diabetic retinopathy. Invest Ophthalmol Vis Sci 1998;39:1358.
Stevens PA, Brown MJ . Genetic variability of the ET-1 and the ETA receptor genes in essential hypertension. J Cardiovasc Pharm 1995;26:S9–12.
Chakravarthy U, Hayes RG, Stitt AW, Douglas A . Increased ET1 expression in ocular tissues of diabetic animals. Invest Ophthalmol 1997;38:2144–51.
Yanagisawa Y, Yanagisawa M, Kapur R, Richardson J, Williams S, Clouthier D, et al. Dual genetic pathways of endothelin-mediated intercellular signalling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development 1998;125:825–36.
Brand M, Le Moullec J-M, Corvol P, Gasc J-M . Ontogeny of endothelins-1 and -3: their receptors, and endothelin converting enzyme-1 in the early human embryo. J Clin Invest 1998;101:549–59.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Warpeha, K., Ah-Fat, F., Harding, S. et al. Dinucleotide repeat polymorphisms in EDN1 and NOS3 are not associated with severe diabetic retinopathy in type 1 or type 2 diabetes. Eye 13, 174–178 (1999). https://doi.org/10.1038/eye.1999.46
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/eye.1999.46